News wire
Drugs and medical devices
Pharmaceuticals, implants and medical devices: safety communications, label changes, approvals and the litigation that follows them.
Source check 5 min ago · Newest item 10 hr ago · 1,441 stories this week · 85 of 90 publishers answering · Browse publishers · RSS feed
Filter stories (1)
Saved on this browser
Drugs and medical devices
Wednesday, October 7
Vape Group, Makers Want In On FDA E-Cig Enforcement Suit
Immunomedics Founder Says Deal Triggered $365M Pay Claim
Kirkland-Led Sheridan Secures $1.345B For 2 Latest Funds
Commerce Finalizes Indian, Turkish Chromium Duty Rates
Seventh Circuit Affirms Dismissal of Employee Claim that Covid-19 Vaccine Requirement Violated Title VII
Tuesday, October 6
AstraZeneca Takes Drug-Pricing Law Challenge To 4th Circ.
1st. Circ. Sees Gaps In Order Halting RFK's Vaccine Advisers
FDA Accuses 10 Retailers Of Selling Unapproved STI Meds
PTAB Panels Should Revamp Their IPR Merits Decisions
4 Firms Advise On $5.8B Option Care Health Take-Private Deal
7th Circ. Judge Hints Precedent Dooms Worker's Vax Fight
Lawsuit Alleges FreeStyle Libre 3 Plus, iLet Insulin Pump Device Failures Caused Death
Pharma Sales Rep. Says Taking Cancer Leave Got Him Fired
A TwIqbal Decision Even John Denver Could Get Behind
Medical Devices; Immunology and Microbiology Devices; Classification of the High Throughput DNA Sequencing for Hereditary Cancer Predisposition Assessment Test System
The Food and Drug Administration (FDA) is classifying the high throughput DNA sequencing for hereditary cancer predisposition assessment test system into class II (special controls). The special controls that apply to the device type are identified in this order and will be part of the codified language for classification of the high throughput DNA sequencing for hereditary cancer predisposition assessment test system. We are taking this action because we have determined that classifying the device into class II will provide a reasonable assurance of the safety and effectiveness of the…
Nova Biomedical® Announces Global Medical Device Correction for StatStrip® Glucose Hospital Meter
WALTHAM, Mass., October 5, 2026 – Nova Biomedical initiated a global Medical Device Correction on July 24, 2026, for the StatStrip® Glucose Hospital Meter System due to a software issue that may cause a glucose result to be associated with the wrong patient. When a patient ID barcode is scanned, pri
Medical Devices; Cardiovascular Devices; Classification of the Hyperoxia Monitoring Device Adjunct to Pulse Oximetry
The Food and Drug Administration (FDA) is classifying the hyperoxia monitoring device adjunct to pulse oximetry into class II (special controls). The special controls that apply to the device type are identified in this order and will be part of the codified language for classification of the hyperoxia monitoring device adjunct to pulse oximetry. We are taking this action because we have determined that classifying the device into class II will provide a reasonable assurance of the safety and effectiveness of the device. We believe this action will also enhance patients' access to beneficial…
Medical Devices; General and Plastic Surgery Devices; Classification of the Focused Ultrasound System for Non-Thermal, Mechanical Tissue Ablation
The Food and Drug Administration (FDA) is classifying the focused ultrasound system for non-thermal, mechanical tissue ablation into class II (special controls). The special controls that apply to the device type are identified in this order and will be part of the codified language for classification of the focused ultrasound system for non-thermal, mechanical tissue ablation. We are taking this action because we have determined that classifying the device into class II will provide a reasonable assurance of the safety and effectiveness of the device. We believe this action will also enhance…
Monday, October 5
Masimo's $634M Apple IP Win Boosted By $184M In Interest
5th Circ. Backs Surgical Stapler Death Suit Dismissal
Read at Law360 Product Liability 5 publishers · 5 reports
Catching Up With Delaware's Chancery Court
'Shocking' COVID Vaccine Appeal Meets Skeptical 2nd Circ.
Chancery Allows Discovery In Boehringer Trade Secrets Fight
Patent Eligibility Bulletin: Claim Solutions, Not Results
Groups Ask DC Circ. To Revive CMS Hemp Program Case
1st Circ. Doubts Harvard Grant Fight Belongs In Claims Court
Shionogi To Buy Texas Biotech IntraBio In $2B Deal
Abbott FCA Deal Shows Enforcement Adequacy Quandaries
IV Tubing Set Correction: ICU Medical Updates Use Instructions for IV Tubing Sets
Black specks and particulate reported in drip chambers of certain ICU Medical IV tubing sets does not affect device safety, performance, or intended use.
Connect the news to your market.
Research the firms, offices and conference relationships behind the headlines.